Abstract: A polyethylene powder having a viscosity average molecular weight of 100,000 or more and 2,500,000 or less, wherein, in a torque curve obtained when kneading the polyethylene powder under the following <Kneading Conditions> using a Labo Plastomill, a slope of a straight line connecting two local maximum points is 2 N·m/min or more and 15 N·m/min or less: <Kneading Conditions> After 24 g of liquid paraffin is kneaded for 10 minutes using a Labo Plastomill Mixer, produced by Toyo Seiki Seisaku-sho, Ltd. (unit model: 30C150, mixer model: R-60) at a set temperature of 114° C. and a rotation speed of 5 rpm, 16 g of the polyethylene powder and 0.4 g of an antioxidant are added thereto, followed by kneading at a rotation speed of 30 rpm for 3 minutes, and then the set temperature is raised from 114° C. to 163° C. over 1 minute; and after the temperature rise, the mixture is kneaded at a set temperature of 163° C. and a rotation speed of 30 rpm for 5 minutes.

Abstract: A polyethylene powder, wherein, when a free induction decay curve obtained by the Carr-Purcell-Meiboom-Gill method in pulsed NMR is subjected to three-component approximation, the relaxation time T of each component and the abundance R of each component satisfy the following <requirement (1)> and <requirement (2)>: <Requirement (1)> An entanglement index at 180° C. determined by (formula I) is 12 to 25 ms: (entanglement index)=T?×R?/(R?+R?)+T?×R?/(R?+R?)?? (formula I) T?: relaxation time (ms) of low-mobility component ? R?: abundance (%) of low-mobility component ? T?: relaxation time (ms) of intermediate component ? R?: abundance (%) of intermediate component ? <Requirement (2)> An intermediate component ratio at 180° C. determined by (formula II) is 0.25 to 0.5: (intermediate component ratio)=R?/(R?+R?)??(formula II).

Abstract: Disclosed is an isolated monoclonal antibody comprising a heavy chain and a light chain, wherein the heavy chain comprises CDR1, CDR2 and CDR3 consisting of amino acid sequences set forth in SEQ ID NOs: 1, 2 and 3, respectively, and the light chain comprises CDR1, CDR2 and CDR3 consisting of amino acid sequences set forth in SEQ ID NOs: 4, 5 and 6, respectively.

Abstract: The present invention relates to an anti-FDP monoclonal antibody selected from the first, second and third monoclonal antibodies having different reactivity towards FDP. The present invention also relates to a reagent and reagent kit for the measurement of FDP and a method for measurement of FDP using the anti-FDP monoclonal antibodies.

Abstract: The present invention relates to an anti-FDP monoclonal antibody selected from the first, second and third monoclonal antibodies having different reactivity towards FDP. The present invention also relates to a reagent and reagent kit for the measurement of FDP and a method for measurement of FDP using the anti-FDP monoclonal antibodies.

Abstract: Method for detecting a measles virus in an analyte, comprising forming a complex of a first monoclonal antibody being capable of binding to a first epitope of a measles virus nuclear protein and being immobilized on a solid phase, a second monoclonal antibody being capable of binding to a second epitope of a measles virus nuclear protein different from the first epitope and being labeled, and a measles virus nuclear protein contained in the analyte, on the solid phase; and detecting the measles virus based on the amount of the label of the complex formed on the solid phase, is disclosed. Membrane assay test device, and membrane assay test kit are also disclosed.

Abstract: A kit or an immuno-chromatographic test device for detection of respiratory syncytial virus (RSV), comprising at least an RSV F protein-recognizing anti-RSV monoclonal antibody produced by hybridoma RSF2-412. An anti-RSV monoclonal antibody recognizing an RS virus F protein, which is selected from the group consisting of an antibody produced by hybridoma RSF2-412, an antibody produced by hybridoma RSF1-1565, and an antibody produced by hybridoma RSF6-255.